Login

Sustainability Spotlight: Joao Bento on CTT Portugal Post | João Bento - CEO of CTT Correios de Portugal, S.A. 00:10:00

Share On Facebook Share On Twitter

João Bento is the CEO of CTT Correios de Portugal, S.A.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Nucleation Capital's Focus on Advanced Nuclear and Decarbonization
00:10:00
Robert Ogór on Navigating Cost Increases and Future Challenges at AMBRA SA | Robert Ogór, President, AMBRA SA.
00:00:00
Shield Therapeutics "ended 2022 in a very very productive state" - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:10:00
Innovative Strategies for Impactful Charitable Giving | Nick Stonestreet, CEO at Ronald Blue Trust
00:10:00
The short film highlighting GWEC and its members includes PNE AG's contributions, featuring an interview with CEO Markus Lesser, starting at a pivotal moment.
00:10:00
Vision of the Month at LarrainVial Asset Management: July 2024 | Alejandro Guín Po, a distinguished financial expert at LarrainVial Asset Management
00:00:00
4d pharma reveals 'phenomenal results' from early stage cancer trial - Duncan Peyton, CEO, 4D Pharma
00:10:00
Resolute Mining: CEO Terry Hulahan on Overcoming Challenges and Gold Production Growth in West Africa|Terry Holohan,Managing Director and Chief Executive Officer,Resolute Mining Ltd.
00:10:00
Dr. Daniel Matjila, CEO of the Public Investment Corporation, receives awards for Asset Management Firm of the Year and Best Corporate.
00:10:00
AdvTech Reports 33% Surge in Headline Earnings per Share, Driven by Enrollment Growth and Efficiency | Roy Douglas, CEO, Advtech Ltd .
00:10:00
Mineral Exploration: Navigating the Future - Insights from Ken Witherly | Ken Witherly , President of Condor Consulting Inc.
00:10:00
specializing in the craft of building great companies|Brian Murray,Partner COO,Craft Ventures

© 2017 - Neuhu+